Exact Mass: 695.307

Exact Mass Matches: 695.307

Found 26 metabolites which its exact mass value is equals to given mass value 695.307, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

RifamycinS

Rifamycin S

C37H45NO12 (695.2942)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins Rifamycin S, a quinone, is an antibiotic against Gram-positive bacteria (including MRSA). Rifamycin S is the oxidized forms of a reversible oxidation-reduction system involving two electrons. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. Rifamycin S can be used for tuberculosis and leprosy[1][2][3].

Elobixibat

2-[2-(2-{[3,3-dibutyl-7-(methylsulfanyl)-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro-1lambda6,5-benzothiazepin-8-yl]oxy}acetamido)-2-phenylacetamido]acetic acid

C36H45N3O7S2 (695.2699)

Kynostatin 227

N-Tert-butyl-3-{2-hydroxy-3-[(1-hydroxy-2-{[1-hydroxy-2-(isoquinolin-5-yloxy)ethylidene]amino}-3-(methylsulphanyl)propylidene)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4-carboximidic acid

C35H45N5O6S2 (695.2811)

Rifamycins

2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1,3,5(28),9,19,21,25-heptaen-13-yl acetate

C37H45NO12 (695.2942)

Z-Vdvad-fmk

2-({2-[(2-{[(benzyloxy)(hydroxy)methylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxy-4-methoxy-4-oxobutylidene}amino)-N-{1-[(5-fluoro-1-methoxy-1,4-dioxopentan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-3-methylbutanimidate

C32H46FN5O11 (695.3178)

Tetramycin

C35H53NO13 (695.3517)

8-Deoxy-3-hydroxyrifamycin S

C37H45NO12 (695.2942)

1alpha,6beta-diacetoxy-9beta-benzoyloxy-15(2)-methylbutyroyloxy-8alpha-nicotynoyloxy-4beta-hydroxy-dihydro-beta-agarofuran

C37H45NO12 (695.2942)

Elobixibat

C36H45N3O7S2 (695.2699)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation

Cbz-DL-Val-DL-Asp(OMe)-DL-Val-DL-Ala-DL-Asp(OMe)-CH2F

C32H46FN5O11 (695.3178)

Z-VDVAD-FMK is a special inhibitor of caspase-2. Z-VDVAD-FMK produces a reduction in Lovastatin-induced apoptosis[1][2][3].

N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine

C27H45N5O16 (695.2861)

D007155 - Immunologic Factors

N-acetyl-(N-acetylglucosaminyl)muramoyl-L-alanyl-D-isoglutamine

C27H45N5O16 (695.2861)

N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-16-[(4-methoxyphenyl)sulfonylamino]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-16-[(4-methoxyphenyl)sulfonylamino]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C37H49N3O8S (695.324)

4-[2-[2-[3-Acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

C27H45N5O16 (695.2861)

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,27,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,27,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate

C37H45NO12 (695.2942)